Milan Criteria for Liver Transplantation

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۲۰ • واحد: cm

حداقل ۰ — حداکثر ۲۰ • واحد: cm

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
milan criteria met
—امتیاز
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Meets Criteria0–0
  • Does Not Meet Criteria1–1
Direct Clinical Answer

The Milan Criteria for Liver Transplantation calculator is designed for bedside assessing suitability of patients for liver transplant with cirrhosis and hepatocellular carcinoma (HCC), recommended by AASLD guidelines in clinical practice. The resulting score directly guides clinician decision-making regarding timing emergent endoscopy, initiating high-dose proton.

Clinical Guidelines & Evidence

Assesses suitability of patients for liver transplant with cirrhosis and hepatocellular carcinoma (HCC), recommended by AASLD guidelines

Clinical Indication

The Milan Criteria for Liver Transplantation is indicated for bedside clinical practice to support Assesses suitability of patients for liver transplant with cirrhosis and hepatocellular carcinoma (HCC), recommended by AASLD guidelines. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration. Clinical exclusion: Count all viable tumors (exclude completely necrotic lesions after treatment).

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: Count all viable tumors (exclude completely necrotic lesions after treatment).

Formula & Variables:

Milan Criteria: (1 tumor ≤5 cm) OR (2-3 tumors, each ≤3 cm) AND no extrahepatic disease AND no major vessel involvement

Input Parameters

NameTypeRequiredDescription
tumor_countstringYesNumber of HCC tumors identified on imaging
single_tumor_sizefloatNoSize of single tumor in cm (only if single tumor)(cm)
largest_tumor_sizefloatNoSize of largest tumor in cm (only if 2-3 tumors)(cm)
extrahepatic_involvementstringYesEvidence of extrahepatic disease (metastases)
major_vessel_involvementstringYesMajor vascular invasion (portal vein or hepatic vein thrombosis)

Score Interpretation & Guidance

RangeStageDescription
0–0Meets CriteriaEligible for liver transplantation
1–1Does Not Meet CriteriaNot eligible for liver transplantation

Evidence-Based References (EBM)

  • Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996 Mar 14;334(11):693-9. doi: 10.1056/NEJM199603143341104.DOI: 10.1056/NEJM199603143341104
  • Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009 Jan;10(1):35-43. doi: 10.1016/S1470-2045(08)70284-5.DOI: 10.1016/S1470-2045(08)70284-5
  • Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, et al. Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience. Liver Transpl. 2011 Oct;17 Suppl 2:S44-57. doi: 10.1002/lt.22365.DOI: 10.1002/lt.22365
  • Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.DOI: 10.1002/hep.29913

Related calculators